Doximity EPS - Earnings per Share 2020-2025 | DOCS
Doximity annual and quarterly earnings per share history from 2020 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Doximity EPS for the quarter ending June 30, 2025 was $0.27, a 28.57% increase year-over-year.
- Doximity EPS for the twelve months ending June 30, 2025 was $1.17, a 46.25% increase year-over-year.
- Doximity 2025 annual EPS was $1.11, a 54.17% increase from 2024.
- Doximity 2024 annual EPS was $0.72, a 35.85% increase from 2023.
- Doximity 2023 annual EPS was $0.53, a 24.29% decline from 2022.
| Doximity Annual EPS | |
|---|---|
| 2025 | $1.11 |
| 2024 | $0.72 |
| 2023 | $0.53 |
| 2022 | $0.70 |
| 2021 | $0.23 |
| 2020 | $0.13 |
| 2019 | $0.01 |
| Doximity Quarterly EPS | |
|---|---|
| 2025-06-30 | $0.27 |
| 2025-03-31 | $0.31 |
| 2024-12-31 | $0.37 |
| 2024-09-30 | $0.22 |
| 2024-06-30 | $0.21 |
| 2024-03-31 | $0.20 |
| 2023-12-31 | $0.24 |
| 2023-09-30 | $0.15 |
| 2023-06-30 | $0.13 |
| 2023-03-31 | $0.15 |
| 2022-12-31 | $0.16 |
| 2022-09-30 | $0.12 |
| 2022-06-30 | $0.10 |
| 2022-03-31 | $0.18 |
| 2021-12-31 | $0.26 |
| 2021-09-30 | $0.17 |
| 2021-06-30 | $0.09 |
| 2021-03-31 | $0.16 |
| 2020-12-31 | $0.05 |
| 2020-09-30 | $0.02 |
| 2020-06-30 | $0.00 |
| 2020-03-31 | $0.00 |
| 2019-03-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $12.055B | $0.570B |
| Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.412B | 59.05 |
| Tempus AI (TEM) | United States | $12.731B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.805B | 80.33 |
| IRhythm Technologies (IRTC) | United States | $5.243B | 0.00 |
| Hinge Health (HNGE) | United States | $4.466B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.752B | 40.46 |
| Privia Health (PRVA) | United States | $2.596B | 192.27 |
| Heartflow (HTFL) | $2.379B | 0.00 | |
| Enovis (ENOV) | United States | $1.715B | 9.06 |
| 10x Genomics (TXG) | United States | $1.663B | 0.00 |
| Phreesia (PHR) | United States | $1.648B | 0.00 |
| Omnicell (OMCL) | United States | $1.458B | 28.10 |
| Schrodinger (SDGR) | United States | $1.425B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.302B | 0.00 |
| Claritev (CTEV) | United States | $1.088B | 0.00 |
| Evolent Health (EVH) | United States | $1.052B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.654B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.568B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.470B | 0.00 |
| Talkspace (TALK) | United States | $0.430B | 128.50 |
| Butterfly Network (BFLY) | United States | $0.355B | 0.00 |
| Carlsmed (CARL) | United States | $0.320B | 0.00 |
| TruBridge (TBRG) | United States | $0.291B | 51.03 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.242B | 0.00 |
| Outset Medical (OM) | United States | $0.237B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.216B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.205B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.192B | 0.00 |
| CapsoVision (CV) | United States | $0.184B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.139B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.133B | 0.00 |
| CareCloud (CCLD) | United States | $0.112B | 5.08 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.077B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.063B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.039B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Zhongchao (ZCMD) | China | $0.022B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.009B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |